Table 1 Demographics and CSF biomarker concentrations
From: Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease
Gender (male/female) | 22/16 | LVF (number of words) | 36.0 (10.8, 17–64) |
Age (years) | 73 (4.7, 65–80) | RPM (/60) | 36.1 (9.8, 15–53) |
Education (years) | 13.4 (3.1, 8–20) | TMT B/A | 2.4 (0.5, 1.5–3.8) |
APOE ε4 carriers (n) | 19 (50 %) | Aβ38 (pg/ml) | 2401 (654, 1057–3505) |
BDNF met carriers (n) | 20 (53 %) | Aβ40 (pg/ml) | 8933 (2456, 3640–13273) |
MMSE (/30) | 28.9 (1.0, 27–30) | Aβ42 (pg/ml) | 996 (430, 351–1859) |
AVLT TL (/75) | 46.2 (8.4, 31–69) | ttau (pg/ml) | 360 (134, 126–660) |
AVLT DR (/15) | 9.8 (2.5, 5–14) | Aβ42/Aβ38 | 0.412 (0.119, 0.136–0.596) |
AVLT %DR | 83.7 (11.7, 55–108) | Aβ42/Aβ40 | 0.110 (0.030, 0.044–0.148) |
BNT (/60) | 54.2 (4.2, 41–60) | Aβ42/ttau | 3.015 (1.246, 0.749–5.128) |
AVF (number of words) | 24.0 (5.5, 14–40) | Amyloid+ (n) | 7 (18 %) |